BioXcel Therapeutics to Present at Bank of America 2022 Biotech SMID Cap Conference

December 1, 2022

https://www.globenewswire.com/news-release/2022/12/01/2565773/0/en/BioXcel-Therapeutics-to-Present-at-Bank-of-America-2022-Biotech-SMID-Cap-Conference.html

NEW HAVEN, Conn., Dec. 01, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq:BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that Vimal Mehta, Ph.D., Founder and Chief Executive Officer, and Matt Wiley, Chief Commercial Officer, will participate in a virtual fireside chat at the Bank of America 2022 Biotech SMID Cap Conference on Wednesday, December 7, 2022 at 1:45 p.m. Eastern Time. Management will discuss the Company’s neuroscience and immuno-oncology programs as well as its artificial intelligence platform used to augment and accelerate the drug candidate discovery and development process. They will also discuss the Company’s ongoing commercial launch strategy for IGALMI™ (dexmedetomidine) sublingual film.

Read more at globenewswire.com

Related news for (BTAI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.